Quant Biomarkers Secures Approval for HKD 6 Million Funding under Hong Kong’s HSITP IGNITE Programme
Basel / Hong Kong – March 2026 Quant Biomarkers (HK) Limited, a subsidiary of Quant…
Read More
Quant Biomarkers AG partners with CHUV and UZH research teams and secures Innosuisse funding to advance clinically actionable cardio-kidney-metabolic biomarkers
Basel, Switzerland – January 2026 – Quant Biomarkers AG has secured approximately CHF 1 million…
Read More